Opinion | ‘We Knew He Was Lying’: What We Heard This Week

“We knew he was lying when he said he was not going to touch this group in particular.” — Georges Benjamin, MD, of the American Public Health Association, discussing the possibility that HHS Secretary Robert F. Kennedy Jr. might remove some advisors on the CDC’s vaccine committee.

“It’s not a good idea to give into this.” — Gordon Schiff, MD, of Brigham and Women’s Hospital and Harvard Medical School in Boston, on his refusal to comply with Trump orders to alter patient safety papers for language.

“The funding freeze is happening in an insidious way, out of public view.” — Steffanie Strathdee, PhD, of the University of California San Diego, on the lack of meeting notices in the Federal Register to review grant applications.

“Vaccine in the refrigerator never yet prevented a single case of infection.” — William Schaffner, MD, of Vanderbilt University Medical Center in Nashville, on flu vaccine production next year.

“I get one or two inquiries a month of similar cases, so this is not so rare.” — Richard Finkel, MD, of St. Jude Children’s Research Hospital in Memphis, on treating spinal muscular atrophy prenatally.

“There’s no upside to this.” — Robert Steinbrook, MD, director of the health research group at Public Citizen, on the purging of thousands of employees at federal health agencies.

“My clinical impression is that post-vaccination syndrome is real.” — Gregory Poland, MD, president of the Atria Health and Research Institute in New York City, on growing evidence that some people develop chronic symptoms after COVID-19 vaccination in very rare cases.

“Abuse is more likely to be missed when there is only one bruise.” — Mary Clyde Pierce, MD, of the Ann & Robert H. Lurie Children’s Hospital of Chicago, on a new screening tool to identify child abuse in the pediatric emergency department.

“Truthfully, we weren’t sure what we would find going into this study.” — Cindy X. Cai, MD, MS, of Wilmer Eye Institute at Johns Hopkins School of Medicine in Baltimore, on research linking semaglutide (Ozempic) use with a potentially blinding eye condition.

Please enable JavaScript to view the

comments powered by Disqus.